Skip to main content

Table 1 Polyclonal sera screens using the CHIKV anti-budding assay

From: A high-throughput screening assay to identify inhibitory antibodies targeting alphavirus release

Sample ID

DPO

% No antibody control

RT-PCR

IgM

IgG

CHIKV status

1:100

1:1000

TT002a

200

3.55

7.09

+ (3 dpo)

+

Recovered

TT002b

640

5.46

10.50

+ (3 dpo)

+

Recovered

TT003

262

12.45

34.00

+ (4 dpo)

+

Recovered

TT009

182

17.94

19.67

+ (7 dpo)

+

+

Recovered

TT010

332

84.79

87.52

−  (4 dpo)

±

+

Recovered

TT015a

3

80.93

98.08

Acute

TT015b

141

20.96

32.59

− (3 dpo)

+

+

Recovered

TT016a

3

70.18

88.52

+

+

Acute

TT016b

128

16.77

15.36

+ (3 dpo)

±

+

Recovered

TT018

4

38.33

73.85

+

Acute

TT024

240

2.00

5.97

N/A

+

Recovered

TT030

150

32.69

16.73

N/A

+

Recovered

TT032

210

3.33

10.14

N/A

+

Recovered

TT035a

135

20.77

15.57

N/A

+

Recovered

TT035b

302

29.89

23.42

N/A

+

Recovered

TT037

210

20.14

10.00

N/A

+

+

Recovered

TT038a

210

26.98

11.10

N/A

+

Recovered

TT038b

952

32.98

24.37

N/A

+

Recovered

TT039

655

28.70

66.26

N/A

+

Recovered

TT046

210

38.78

71.38

N/A

+

Recovered

TT047a

45

8.16

11.56

N/A

+

+

Recovered

TT047b

130

5.00

10.00

N/A

+

+

Recovered

TT052

360

6.29

16.27

N/A

±

+

Recovered

TT054

330

2.96

9.98

N/A

 ± 

 + 

Recovered

TT059a

10

15.11

19.87

+

±

Acute

TT059b

145

5.81

15.28

−  (10 dpo)

+

Recovered

TT059c

284

17.47

12.61

− (10 dpo)

+

Recovered

TT065

13

29.41

72.01

+

Recovered

TT068

212

70.55

62.23

− (5 dpo)

+

+

Recovered

TT070

7

10.65

39.41

+

Recovered

TT075

12

7.96

36.37

+

Recovered

TT076

6

6.06

12.28

+

Recovered

TT078

6

12.80

53.41

+

Recovered

TT080

11

7.23

20.38

±

Acute

TT087

150

50.79

103.31

N/A

+

Recovered

TT090

460

46.95

42.65

N/A

+

Recovered

TT092

360

28.44

49.20

N/A

+

Recovered

TT095a

4

92.49

95.52

Negative

TT095b

22

86.41

105.19

Negative

TT095c

147

119.61

125.85

− (4 dpo)

Negative

TT095d

399

112.67

104.57

− (4 dpo)

Negative

TT101

5

68.16

64.41

Negative

TT103

30

7.68

16.32

+

Recovered

TT107

30

8.11

20.72

+

Recovered

TT114

10

42.24

79.73

+

Recovered

TT120

11

96.75

101.83

±

+

Recovered

TT122

23

35.17

30.08

+

Recovered

  1. RT-PCR and ELISA results are indicated positive (+), negative (−), or equivocal (±) where applicable. Some volunteers were previously screened by RT-PCR for CHIKV during acute stages of infection. Results from their initial screens are denoted with the dpo at that time. Anti-budding assay results are shown as percentage of nano-luciferase reading of wells containing no antibody (% control) and represent the mean ± SD of triplicate measurements. All results shown carry a CV score of ≤ 15%